Auszug aus dem Newsletter:

"ENSIA is thrilled to announce a neuro-mucosal treatment, which is now available for ENS sufferers!  This treatment will take place in Leipzig, Germany and the treatment methods are based upon scientific research and developments by a world-renowned stem cell and regenerative medicine researcher. 

The treatment methods are based upon the ABC principle: 1) activation of endogenous stem cells, 2) boosting (“internal proliferation”), and 3) commitment – signaling cells to implement a specific job for regeneration.  A variety of individualized treatment methods will be used ranging from topical applications – such as surface applications, pulsating micro-laser, and injections – to systemic treatments to surgery.  The method utilized will be tailored to the specific problem.  Various conditions targeted include:  empty nose syndrome (ENS), rhinitis, atrophic rhinitis (AR), sinusitis, post-nasal drip, nasal dryness, mucosal and cilia atrophy, mucosal apoptosis, nerve damage, scar tissue, neuropathy, anosmia and hyposmia (total or partial loss of smell), surgical wound damage, and others."

Weitergehende Informationen finden Sie unter nachfolgendem Link!

Herzliche Grüße,

Ihr Dr. Robert Bodlaj